Frequently Asked
Questions

General FAQ’s

How does PGx testing benefit the physician?

Improve & revolutionize patient care though PGx testing, Actionable data at the point of care, Tools to follow medical necessity protocols and track outcomes, Incorporating personalized medicine techniques is a competitive advantage, Provides ancillary revenue source for your practice (Precision Genetics LCS Model)

How does PGx testing benefit the patient?

Not everyone responds to a drug or medication in the same way, each individual has their own unique genetic makeup, which affects the way their bodies respond to a disease and treatment. PGx uses information about a person’s genetic makeup to choose the drugs and drug doses that are likely to work best for that person as well as determining the proper drug-to-drug combinations

How much lab space is needed?

Standard rule of thumb is a minimum of 300 sq. ft. and 26’ of countertop space.

How many technicians are required?

Number of technicians depends on the number of samples being run day-to-day. One of the value propositions of the LCS model is that we calculate how much staff you will need (accessioners, technicians, directors, etc.) to process your anticipated volumes, provide standard operating procedures and default processing schedules, and provide on site training to get your team up to speed.

Do the technicians require molecular training?

No. They do require experience in pipetting.

Is a medical director required when implementing a PGx lab?

It depends if the existing highly complex CLIA lab has a medical director. Rule of thumb is that a medical director is needed for both urine toxicology screening as well as molecular testing. Commonly a PHD or Pathologist that has a minimum of 2 years experience in running a highly complex lab.

What is the estimated turnaround time to implement and validate the PGx lab?

Lab setup and configuration is a phased process:

  • 4 weeks to secure all ancillary and capital equipment
  • 2 week to train on the LifeTech equipment
  • 2 weeks to validate the genetic testing and train the technicians/staff

qNomics FAQ’s

What genetic markers are we testing?

We test genetic markers that look at enzymatic functionality and liver metabolism in a variety of different pathways including Psychiatric, Cardiovascular, Pain Management, ADHD, and a Comprehensive (Covers all areas).

How are we using the genetic data?

Personalized medicine uses your DNA to help your doctor make more effective treatment decisions for your health. This program is focused on making sure that our medications are safe and beneficial for you. Said more simply, this program will help make sure that the medicines you are prescribed work for you. Without this testing, medicines may be prescribed that wont work with your DNA.

Who will have access to my results?

Your DNA information will never be shared with [Company] and will not impact our [Company] coverage or benefits. The DNA testing results are confidential and securely maintained just like any other medical record. qNomics will work with the Know Your Rx Pharmacy Coalition to provide an analysis of your DNA and maintain your healthcare information in accordance with the Health Insurance Portability and Accountability Act (HIPAA). You may allow your results to be used—with your identifying information removed—in medical research.

How is the employee’s physician involved in the process?

Delivery of the employee’s results is at the discretion of the employee, the employer’s wellness initiative (on-premise medical professionals). Once an employee’s tests results are in they can be securely transferred to their physician(s) so it can be submitted and become a part of the employee’s medical record. The results are portable between medical professionals.

How does the platform impact GINA laws? (Genetic Information Nondiscrimination Act)

Participation in the program is completely optional. This platform is in compliance with GINA laws and the employer will never have access to the employees DNA analysis.

How do you determine who should be tested?

We request 12 months of historical claims data. We then analyze the dataset in the following areas: population demographics,
drug spend,
most expensive conditions, who is a good candidate for pharmacogenetic testing (PGx), how at risk is the client population,
how much is spent on PGx related drugs,
what conditions are most affected, and the likely outcomes of PGx testing.

How do we determine which employees are at risk?

We identify cost savings and wellness opportunity by identifying generic solutions where they apply, optimizing retail pharmacy savings, and identifying therapeutic alternatives or a reduction in overall meds.

How many times does an employee need to be tested?

For an employee and their covered dependents this is a one-time test as your DNA makeup does not change.

Will my covered dependents need to be tested?

We highly encourage that all covered lives should be tested especially if any of them are dealing with any type of health issues. We do however; leave that decision up to the parent or guardian of the dependents.

Who else is using the platform?

A list of references can be provided upon request.

How many covered lives do we have?

Approximately 70,000 covered lives are in the program.

What is the cost of the test?

Pricing can be structured in a variety of ways. Those variables include total number of covered lives, a list of services being provided, or potential risk sharing models. If you would like a quote please consult with a qNomics sales representative.

What is an Adverse Drug Reaction or Event (ADR/ADE)?

Adverse drug reactions (ADRs) are unwanted drug effects that have considerable economic as well as clinical costs as they often lead to hospital admission, extended hospital stays and ER visits.

What is polypharmacy?

Polypharmacy refers to the use of a large number of medications, commonly considered to be the use of five or more.

When do we start to recognize quantifiable savings or potential on ROI?

Depending on enrollment and participation, savings are immediately recognized once prescription changes take place. Long term savings related to ADRs and ADEs are recognized over time. Our standard contract terms for the program is 3 years.

How does this platform impact our overall healthcare and medical claims?

30% of hospital admissions are related to ADRs and ADEs. The goal of the platform is to minimize adverse drug reactions which will reduce ER visits, hospital admissions and readmissions, extended hospital stays, physician visits and provide less days missed from work.

How long does it take to implement the platform?

This varies on total number of enrolled participants. Average implementation is 4-6 weeks.

How do we educate the employee population?

Once we have identified the audience on behalf of the employer we secure contact information of their covered lives. We communicate via mail, emails, phone messages, internal communication channels, and wellness providers.

Is there an employee app that can be used?

Yes. We have an employee-facing app that can be customized on behalf of the company.

What is the potential impact on my workforce?

Happy, healthy employees mean lower turnover, improved productivity, and less absenteeism. Help your company have an ideal workplace and culture for your employees

Have Questions About Us?

Our personalized approach to what we do extends beyond our genetics lab.  We, the team, are committed to providing patients, providers, and other labs the quality services and results we put our name behind.